04Feb 2018

MULTIPLE SCLEROSIS IN QATIF.

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Introduction:Multiple sclerosis (MS) is an autoimmune disorder that attacks the central nervous system, characterized by dissemination in space and time which results in a wide range of neurological manifestations. In this review, we discuss MS in Qatif which is small city in Saudi Arabia with a population around 500 thousands that descend from almost one ethnic background. Materials and Methods: A comprehensive literature search was performed to extract data regarding MS in general and MS in Qatif central hospital population in specific and statistical testing to find any correlation between the disease and factors thought to affect it in QHC population. Results:Data have shown no relation between MS and ethnic background, age,infection and obesity in QHC population . This review will discuss the factors influencing MS; correlate their effects with disease pathology, their interaction in the context of disease development. Conclusion:Understanding MS development could help find ways to treat MS and influence factors which affect the development of the disease.


  1. org. 2017.?national multiple sclerosis society. [ONLINE] Available at:?http://www.nationalmssociety.org/. [Accessed 13 August 2017]
  2. T Kj?lhede, K Vissing, U Dalgas. 2017.?Multiple Sclerosis Journal. [ONLINE] Available at:?http://journals.sagepub.com/doi/abs/10.1177/1352458512437418. [Accessed 13 August 2017].
  3. AndriusKavaliunas, Ali Manouchehrinia, LeszekStawiarz, Ryan Ramanujam, Jonas Agholme, Anna Karin Hedstr?m, OmidBeiki, Anna Glaser, Jan Hillert. 2017.?Importance of early treatment initiation in the clinical course of multiple sclerosis. [ONLINE] Available at:?http://journals.sagepub.com/doi/full/10.1177/1352458516675039. [Accessed 13 August 2017
  4. Anon, (2018). [online] Available at: http://Keegan bm and noseworthyjh. (2018). Nihgov. Retrieved 9 February, 2018, from https:/www.ncbi.nlm.nih.gov/pubmed/11818475 In-text citation: (Keegan bm and noseworthyjh, 2018) [Accessed 9 Feb. 2018].
  5. National Multiple Sclerosis Society. (2018).?Diagnosing MS. [online] Available at: https://www.nationalmssociety.org/Symptoms-Diagnosis/Diagnosing-MS [Accessed 9 Feb. 2018].
  6. Mohammed, E. (2018).?Multiple sclerosis is prominent in the Gulf states: Review.
  7. Anon, (2018). [online] Available at: http://journals.sagepub.com/doi/full/10.1177/1352458517709957 [Accessed 9 Feb. 2018].
  8. Bohlega, S., Inshasi, J., Tahan, A., Madani, A., Qahtani, H. and Rieckmann, P. (2018).?Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
  9. (2018).?Multiple Sclerosis by the Numbers: Facts, Statistics, and You. [online] Available at: https://www.healthline.com/health/multiple-sclerosis/facts-statistics-infographic [Accessed 9 Feb. 2018].
  10. JH, K. (2018).?Multiple sclerosis. - PubMed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11818475 [Accessed 9 Feb. 2018].
  11. chron.com. (2018).?Difference Between Multiple Sclerosis and Myasthenia Gravis. [online] Available at: http://livehealthy.chron.com/difference-between-multiple-sclerosis-myasthenia-gravis-1324.html [Accessed 9 Feb. 2018].
  12. E, M. (2018).?Multiple sclerosis: geoepidemiology, genetics and the environment. - PubMed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19932200 [Accessed 9 Feb. 2018].
  13. Loma, I. and Heyman, R. (2018).?Multiple Sclerosis: Pathogenesis and Treatment.
  14. Global-disease-burden.healthgrove.com. (2018).?Multiple Sclerosis in Saudi Arabia. [online] Available at: http://global-disease-burden.healthgrove.com/l/56160/Multiple-Sclerosis-in-Saudi-Arabia [Accessed 9 Feb. 2018].

[Mohammed Nasser Alsadiq and Tomasz Slomka PhD. (2018); MULTIPLE SCLEROSIS IN QATIF. Int. J. of Adv. Res. 6 (Feb). 408-411] (ISSN 2320-5407). www.journalijar.com


Mohammed Nasser Alsadiq
Qatif central hospital

DOI:


Article DOI: 10.21474/IJAR01/6452      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6452